Katherine B. Santosa

Katherine B. Santosa

Auto-generated profile, based on publicly available information

Katherine B. Santosa

Section of Plastic Surgery, Department of Surgery, University of Michigan Health System, Ann Arbor, MI

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2018 in JAMA Surgery
Verified
Journal Article
Closed access
PDF file
KSKatherine B. Santosa
Katherine B. Santosa
JQJi Qi
Ji Qi
HKHyungjin M. Kim
Hyungjin M. Kim
JHJennifer B. Hamill
Jennifer B. Hamill
EWEdwin G. Wilkins
Edwin G. Wilkins
APAndrea L. Pusic
Andrea L. Pusic
Importance Previous outcome studies comparing implant and autologous breast reconstruction techniques have been limited by short-term follow-up, single-center design, and a lack of rigorous patient-reported outcome data. An understanding of the expected satisfaction and breast-related quality of life associated with each type of procedure is central to the decision-making process. Objective To determine outcomes reported by patients undergoing postmastectomy breast reconstruction using implant or autologous techniques 2 years after surgery. Design, Setting, and Participants Patients were recruited from 11 centers (57 plastic surgeons) across North America for the Mastectomy Reconstruction Outcomes Consortium study, a prospective, multicenter trial, from February 1, 2012, to July 31, 2015. Women undergoing immediate breast reconstruction using implant or autologous tissue reconstruction after mastectomy for cancer treatment or prophylaxis were eligible. Overall, 2013 women (1490 implant and 523 autologous tissue reconstruction) met the inclusion criteria. All patients included in this analysis had 2 years of follow-up. Exposures Procedure type (ie, implant vs autologous tissue reconstruction). Main Outcomes and Measures The primary outcomes of interest were scores on the BREAST-Q, a validated, condition-specific, patient-reported outcome instrument, which were collected prior to and at 2 years after surgery. The following 4 domains of the BREAST-Q reconstruction module were evaluated: satisfaction with breasts, psychosocial well-being, physical well-being, and sexual well-being. Responses from each scale were summed and transformed on a 0 to 100 scale, with higher numbers representing greater satisfaction or quality of life. Results Of the 2013 women in the study (mean [SD] age, 48.1 [10.5] years for the group that underwent implant-based reconstruction and 51.6 [8.7] years for the group that underwent autologous reconstruction), 1217 (60.5%) completed questionnaires at 2 years after reconstruction. After controlling for baseline patient characteristics, patients who underwent autologous reconstruction had greater satisfaction with their breasts (difference, 7.94; 95% CI, 5.68-10.20;P < .001), psychosocial well-being (difference, 3.27; 95% CI, 1.25-5.29;P = .002), and sexual well-being (difference, 5.53; 95% CI, 2.95-8.11;P < .001) at 2 years compared with patients who underwent implant reconstruction. Conclusions and Relevance At 2 years, patients who underwent autologous reconstruction were more satisfied with their breasts and had greater psychosocial well-being and sexual well-being than did those who underwent implant reconstruction. These findings can inform patients and their clinicians about expected satisfaction and quality of life outcomes of autologous vs implant-based procedures and further support the adoption of shared decision making in clinical practice.

31 January 2011 in Muscle & Nerve
Verified
Journal Article
Closed access
PDF file
AMAmy M. Moore
Amy M. Moore
MMMatthew Macewan
Matthew Macewan
KSKatherine B. Santosa
Katherine B. Santosa
KCKristofer E. Chenard
Kristofer E. Chenard
WRWilson Z. Ray
Wilson Z. Ray
PJPhilip J. Johnson
Philip J. Johnson

1 March 2018 in Journal of the American College of Surgeons
Verified
Journal Article
Closed access
JHJessica M. Hasak
Jessica M. Hasak
CBCarrie L. Roth Bettlach
Carrie L. Roth Bettlach
KSKatherine B. Santosa
Katherine B. Santosa
ELEllen L. Larson
Ellen L. Larson
JSJean Stroud
Jean Stroud
SMSusan Mackinnon
Susan Mackinnon
Our country is in the midst of an opioid epidemic. Although the problem is multifactorial, one issue is the presence of excess prescription opioid medications circulating in our communities. Our objective was to determine whether dissemination of an educational brochure would improve the disposal of unused opioids after surgery. Eligible surgery patients from an upper extremity/peripheral nerve clinic were enrolled into this prospective before and after study between February 2017 and September 2017. Patients who reported opioid use preoperatively were excluded from this study. The same survey was administered to the group of patients who did not receive the intervention and to those who did receive the intervention. Our primary endpoint was the proportion of patients who disposed of unused opioid medications. A total of 334 patients were studied: 164 who did not receive the brochure and 170 who received the brochure. Seventy-six patients were excluded for preoperative opioid use. After dissemination of the brochure, there was a significant increase in the proportion of patients who disposed of their unused opioids (11% vs 22%, p = 0.02). Of those who disposed of their opioids, there was no significant difference in the proportion of patients from each group who disposed in a manner that was recommended by the brochure (43% vs 64%, p = 0.19). Dissemination of the educational brochure improved disposal of unused opioids after surgery. This low-cost, easily implemented intervention can improve disposal of unused opioids and ultimately, decrease the amount of excess opioids circulating in our communities.

1 December 2016 in Journal of the American College of Surgeons
Verified
Journal Article
Closed access
KSKatherine B. Santosa
Katherine B. Santosa
JQJi Qi
Ji Qi
HKHyungjin M. Kim
Hyungjin M. Kim
JHJennifer B. Hamill
Jennifer B. Hamill
APAndrea L. Pusic
Andrea L. Pusic
EWEdwin G. Wilkins
Edwin G. Wilkins
Although >40% of new breast cancer diagnoses in the US are in older women, few studies have assessed the outcomes of post-mastectomy reconstruction in this population. Our objective was to evaluate age effects on postoperative complications and patient-reported outcomes in women undergoing breast reconstruction, and to investigate whether age effects differ between reconstructive procedure types. Eligible patients in the Mastectomy Reconstruction Outcomes Consortium study from 11 institutions (57 providers) in North America were analyzed. Two-year complications and patient-reported outcomes via BREAST-Q domains were compared across younger (younger than 45 years), middle-aged (45 to 60 years), and older (older than 60 years) women. Mixed-effects regression models were used, controlling for a range of demographic and clinical covariates. A total of 1,531 patients were studied: 494 younger, 803 middle-aged, and 234 older. Age was not a significant predictor of complications. For sexual well-being 2 years post-reconstruction, older women reported 4.25 (p = 0.04) higher mean scores with implant procedures, and 10.39 (p < 0.01) higher mean scores with autologous procedures compared with younger women. No age effect was seen with implant procedures with regard to physical and psychosocial well-being; however, older women who underwent autologous procedures reported 6.07 (p < 0.01) higher physical, and 8.21 (p < 0.01) higher psychosocial well-being scores than younger women. Age did not significantly affect complication rates. Older women demonstrated higher sexual well-being for both procedures, and better satisfaction and physical and psychosocial well-being than younger women with autologous procedures. Post-mastectomy reconstruction is a viable option for older patients, with risks and benefits comparable with those in younger women.

1 October 2016 in Plastic and Reconstructive Surgery
Verified
Journal Article
Closed access
KSKatherine B. Santosa
Katherine B. Santosa
XCXiaoxue Chen
Xiaoxue Chen
JQJi M.S. Qi
Ji M.S. Qi
TBTiffany N. S. Ballard
Tiffany N. S. Ballard
HKHyungjin M. Sc.D. Kim
Hyungjin M. Sc.D. Kim
EWEdwin G. M.D. Wilkins
Edwin G. M.D. Wilkins
Background: The ideal timing of postmastectomy radiation therapy (PMRT) in the setting of two-stage implant-based breast reconstruction remains unclear. In this cohort study, the authors sought to determine whether complication rates differed between patients who received PMRT following tissue expander placement (TE-XRT) and those who received PMRT after exchange for permanent implants (Implant-XRT) utilizing using prospective, multicenter data. Methods: Eligible patients in the Mastectomy Reconstruction Outcomes Consortium study from 11 institutions across North America were included in the analysis. All patients had at least 6-month follow-up after their last intervention (i.e., implant exchange for TE-XRT patients, and radiation for Implant-XRT patients). Complications including seroma, hematoma, infection, wound dehiscence, capsular contracture, and implant loss were recorded. Results: The authors identified a total of 150 patients who underwent immediate, two-stage implant-based breast reconstruction and received PMRT. Of these, there were TE-XRT 104 patients (69.3 percent) and 46 (30.7 percent) Implant-XRT patients. There were no differences in the incidence of any complications or complications leading to reconstructive failure between the two cohorts. After adjusting for patient characteristics and site effect, the timing of PMRT (i.e., TE-XRT versus Implant-XRT) was not a significant predictor in the development of any complication, a major complication, or reconstructive failure. Conclusion: In the setting of PMRT and two-stage implant-based reconstruction, patients who received PMRT after expander placement (TE-XRT) did not have a higher incidence or increased odds of developing complications than those who received PMRT after exchange for a permanent implant (Implant-XRT). CLINICAL QUESTION/LEVEL OF EVIDENCE: Therapeutic, III.

23 July 2019 in Surgery
Verified
Journal Article
Closed access
KSKatherine B. Santosa
Katherine B. Santosa
HHHsou-Mei Hu
Hsou-Mei Hu
CBChad M. Brummett
Chad M. Brummett
MOMargaret A. Olsen
Margaret A. Olsen
MEMichael J. Englesbe
Michael J. Englesbe
JWJennifer F. Waljee
Jennifer F. Waljee